Technical Analysis for ERGO - Ergomed Plc

Grade Last Price % Change Price Change
D 1070.0 -3.60% -40.00
ERGO closed down 3.6 percent on Friday, April 16, 2021, on 1.34 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical ERGO trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Walk Weakness -3.60%
Inside Day Range Contraction -3.60%
Lower Bollinger Band Touch Weakness -3.60%
Lower Bollinger Band Walk Weakness -8.15%
Outside Day Range Expansion -8.15%
Lower Bollinger Band Touch Weakness -8.15%
Lower Bollinger Band Walk Weakness -1.38%
Older End-of-Day Signals for ERGO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Ergomed Plc Description

Ergomed plc is a provider of drug development services to the pharmaceutical industry. The Company operates through two segments: clinical research services (CRS), and drug safety and medical information services (DS&MI). It provides a range of clinical trial planning, management and monitoring services. It is focused on oncology, neurology and immunology, and the development of orphan drugs. It has two businesses: Services Business and Co-Development Business. The Services Business is a clinical research business providing services to the pharmaceutical and biotechnology industry. The Co-Development Business is a portfolio of partnerships with pharmaceutical and biotechnology companies, providing its drug development services in exchange for a carried interest in any revenues attributable to the drug asset, including out licensing milestones, as well as sales of the product. It provides clinical development, trial management and pharmacovigilance services to over 100 clients.


Sector: Healthcare
Industry: Biotechnology
Keywords: Health Information Research Pharmaceutical Revenue Biotechnology Ships Clinic Planning Monitoring Safety Partnerships Oncology Drugs Clinical Trial Pharmaceutical Industry Immunology Search Service Drug Development Clinical Research Biotechnology Companies Pharmaceuticals Policy Contract Research Organizations Parexel Biotechnology Industry Clinical Pharmacology Clinical Research Services Drug Development Services Medical Information Services Pharmacovigilance

Is ERGO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1295.0
52 Week Low 362.0
Average Volume 79,625
200-Day Moving Average 894.74
50-Day Moving Average 1194.80
20-Day Moving Average 1163.50
10-Day Moving Average 1117.00
Average True Range 60.81
ADX 27.4
+DI 10.31
-DI 12.44
Chandelier Exit (Long, 3 ATRs ) 1077.58
Chandelier Exit (Short, 3 ATRs ) 1235.42
Upper Bollinger Band 1273.32
Lower Bollinger Band 1053.68
Percent B (%b) 0.07
BandWidth 18.88
MACD Line -28.11
MACD Signal Line -19.56
MACD Histogram -8.5535
Fundamentals Value
Market Cap 521.28 Million
Num Shares 48.7 Million
EPS 12.50
Price-to-Earnings (P/E) Ratio 85.60
Price-to-Sales 5.47
Price-to-Book 8.98
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1130.00
Resistance 3 (R3) 1136.67 1123.33 1120.00
Resistance 2 (R2) 1123.33 1108.05 1120.00 1116.66
Resistance 1 (R1) 1096.67 1098.61 1090.00 1090.00 1113.33
Pivot Point 1083.33 1083.33 1080.00 1080.00 1083.33
Support 1 (S1) 1056.67 1068.05 1050.00 1050.00 1026.67
Support 2 (S2) 1043.33 1058.61 1040.00 1023.34
Support 3 (S3) 1016.67 1043.33 1020.00
Support 4 (S4) 1010.00